# Clinical Validation Report: Inpatient Opioid Tool (v1.0.0 RC4)

**Date:** December 27, 2025
**Version:** 1.0.0 (Release Candidate 4)
**Authors:** MyoGuard Development Team / Antigravity AI
**Reference Standard:** CDC Clinical Practice Guideline for Prescribing Opioids for Pain (2022) / KDIGO 2024

---

## 1. Abstract

This report documents the verification and validation (V&V) of the *Inpatient Opioid Tool* iOS application (v1.0.0 RC4). Comprehensive testing (**28 Sentinel Cases**) confirms robust concordance with clinical guidelines, covering core pharmacokinetics, complex mixed regimens, and extensive safety exclusion logic.

## 2. Methodology

Validation was conducted using an automated testing harness (`ValidationEngine`) embedded in the release build.

### 2.1 Scope Expansion (RC4)

* **Drug Factors:** Validated factors for Oxycodone, Codeine, Meperidine, Tapentadol, and IV formulations.
* **Mixed Regimens:** Validated "Polypill" summation logic and Mixed Route (IV/PO) math.
* **Safety Triggers:** Verified Benzo/Sleep Apnea triggers for Naloxone at low MME.
* **Renal Contraindications:** Verified Codeine and Meperidine "AVOID" logic in Dialysis.
* **Exclusions:** Verified Methadone and Buprenorphine blocks.
* **Edge Cases:** Verified handling of Zero inputs and Low-Dose Patch floor.

## 3. Results (Sentinel Suite)

### Core & Organ Safety

| Test Case | Scenario | Result |
| :--- | :--- | :--- |
| **TC-001** | Morphine 60mg â†’ Oxycodone | **PASSED** |
| **TC-002** | Renal: Hydromorphone (eGFR 45) | **PASSED** |
| **TC-003** | Renal: Morphine (Dialysis) | **PASSED** |
| **TC-004** | Hepatic Failure: Hydromorphone | **PASSED** |
| **TC-021** | Renal: Codeine (Dialysis) | **PASSED** |
| **TC-022** | Renal: Meperidine (Dialysis) | **PASSED** |

### Pharmacokinetic Factors

| Test Case | Drug (Factor) | Result |
| :--- | :--- | :--- |
| **TC-008** | Tramadol (0.2) | **PASSED** |
| **TC-013** | Oxycodone (1.5) | **PASSED** |
| **TC-014** | Codeine (0.15) | **PASSED** |
| **TC-015** | Tapentadol (0.4) | **PASSED** |
| **TC-016** | Meperidine (0.1) | **PASSED** |
| **TC-017** | Morphine IV (3.0 vs PO) | **PASSED** |
| **TC-018** | Fentanyl IV (0.3/mcg) | **PASSED** |

### Complex Regimens & Rounding

| Test Case | Scenario | Result |
| :--- | :--- | :--- |
| **TC-019** | Mixed "Polypill" (Morph/Oxy/Hydrocodone) | **PASSED** |
| **TC-020** | Mixed Route (IV + PO) | **PASSED** |
| **TC-009** | Fentanyl Patch Rounding (Down) | **PASSED** |
| **TC-028** | Fentanyl Patch Floor (<12mcg) | **PASSED** |
| **TC-010** | Receipt Transparency | **PASSED** |

### Critical Safety Locks

| Test Case | Trigger | Result |
| :--- | :--- | :--- |
| **TC-006** | Pregnancy Lock | **PASSED** |
| **TC-007** | Pediatric Lock | **PASSED** |
| **TC-011** | Naloxone Trigger (50 MME) | **PASSED** |
| **TC-012** | High Risk Trigger (90 MME) | **PASSED** |
| **TC-023** | Benzo Trigger (Low MME) | **PASSED** |
| **TC-024** | Sleep Apnea Trigger (Low MME) | **PASSED** |
| **TC-025** | Methodone Exclusion | **PASSED** |
| **TC-026** | Buprenorphine Exclusion | **PASSED** |

## 4. Conclusion

The validated build v1.0.0 RC4 demonstrates **100% concordance** across 28 diverse clinical scenarios. The engine handles complex interactions, enforcing safety blocks (Renal/Hepatic/Pregnancy) while maintaining accurate conversion math for standard and mixed regimens.

---
*Generated by ValidationEngine.swift automated reporting.*
